Similarly, there was a significant elevation in ATG9A concentrations in the kidneys of the CIS-treated Gal-3 KO mice compared to Gal-3 KO sham control mice, also demonstrating statistical significance (p < 0.001) (Figure 10D). Here, ATG9A is linked to in situ carcinoma.